RankingsPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Earnings per share

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.05T
P/E ratio
22.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 202528.4+198.11%
Mar 31, 20249.5-82.47%
Mar 31, 202354.2-19.14%
Mar 31, 202267.1+3.31%
Mar 31, 202164.9-37.66%
Mar 31, 2020104.2-9.47%
Mar 31, 2019115.1+41.84%
Mar 31, 201881.1-21.78%
Mar 31, 2017103.7+15.53%
Mar 31, 201689.8+45.93%
Mar 31, 201561.5+49.45%
Mar 31, 201441.2+2.19%
Mar 31, 201340.3-76.23%
Mar 31, 2012169.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)